# Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection

> **NCT02249546** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 654 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** N-acetylcysteine + PPI-amoxicillin-clarithromycin
- **DRUG:** PPI-amoxicillin-clarithromycin

## Key facts

- **NCT ID:** NCT02249546
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2016-08
- **Final completion:** 2016-10
- **Target enrollment:** 654 (ESTIMATED)
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02249546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02249546, "Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02249546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*